Understanding the genetic mechanisms linking genome variations, such as single-nucleotide polymorphisms (SNPs), to phenotypes ...
The global DNA methylation market size was valued at US$ 1.9 Bn in 2025 and is projected to reach US$ 7.7 Bn by 2036, growing ...
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
SHERLOCK, a rapid CRISPR-based diagnostic, detects Candida auris and antifungal resistance mutations in patient samples in under an hour.
Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by ...
Throughout his career Mr Peacock has demonstrated strong entrepreneurial and innovation success through start-ups, digital commercial innovation and funding access initiatives. Vaxxas Chair, Ms Sarah ...
Morning Overview on MSN
Quantum-powered proteins could launch a shocking new biotech era
Quantum physics is no longer confined to cryogenic chips and vacuum chambers. It is starting to seep into the machinery of ...
In recent years, interest has grown around two investigational peptides, BPC-157 and TB-500, proposed as part of a combined research-oriented protocol to explore tissue regeneration, angiogenesis, and ...
This article explores how next-generation vaccines are expanding beyond infectious disease to target chronic conditions while ...
The FDA designates ARB1002 as an orphan drug, highlighting its potential as a novel treatment for pancreatic cancer amid limited options. The FDA has granted orphan drug designation (ODD) to ARB1002, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results